| Net Cash Provided by (Used in) Operating Activities |
-318K |
USD |
-21.5% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
1.98B |
shares |
|
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
175M |
shares |
|
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-318K |
USD |
-21.5% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
148M |
USD |
+326% |
Q3 2025 |
Q3 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-270M |
USD |
-1310% |
Q3 2025 |
Q3 2025 |
| Property, Plant and Equipment, Gross |
27.6M |
USD |
|
Q3 2025 |
Q3 2025 |
| Operating Lease, Liability, Current |
1.85M |
USD |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2025 |
Q2 2025 |
| Preferred Stock, Shares Authorized |
20M |
shares |
-80% |
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
0 |
USD |
|
Q2 2025 |
Q2 2025 |
| Additional Paid in Capital |
0 |
USD |
-100% |
Q4 2023 |
FY 2023 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2025 |
Q2 2025 |
| Depreciation, Depletion and Amortization |
900K |
USD |
-25% |
Q3 2025 |
Q3 2025 |
| Share-based Payment Arrangement, Expense |
5.25M |
USD |
+205% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |